Jacob T Brown

11PUBLICATIONS
34CO-AUTHORS
Child and adolescent developmentToxicology (incl. clinical toxicology)PharmacogenomicsCurriculum and pedagogy theory and developmentSoftware and application security
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 11, 2026
Association of Atomoxetine Discontinuation Patterns with CYP2D6 Phenotype in Children and Adolescents with Attention Deficit Hyperactivity Disorder.

|Feb 06, 2026
Protracted escitalopram discontinuation syndrome and serotonin toxicity associated with CYP2C19 poor metabolism: A case report.

Elizabeth H Tran, Jeffrey R Bishop, Jacob T Brown

|Dec 20, 2023
Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.

Shen Cheng, Mahmoud Al-Kofahi, J Steven Leeder

|Apr 09, 2023
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.

Chad A Bousman, James M Stevenson, Laura B Ramsey

|Oct 31, 2022
Knowledge and attitudes of incoming pharmacy students toward pharmacogenomics and survey reliability.

Ya-Feng Wen, Pamala A Jacobson, William S Oetting

|Jul 14, 2022
Perceptions of pharmacogenetic exceptionalism and the implications for clinical management within an electronic health record.

Tiana Butler, Jacob Brown, Pamala A Jacobson

Pageof 2

Frequent Collaborators

4 joint publications

David Stenehjem

4 joint publications

Jeffrey R Bishop

3 joint publications

Tiana Luczak

2 joint publications

Pamala A Jacobson